ELBIT IMAGING LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 354 ILa | +0.28% |
|
+0.28% | -10.22% |
| 03-31 | Elbit Imaging Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Elbit Imaging Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| Sales 2022 | - | Sales 2023 | 0.33 122.63 26.23 | Capitalization | 36.24M 13.55B 2.9B |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 | Net income 2023 | -18M -6.73B -1.44B | EV / Sales 2022 | - |
| Net cash position 2022 | 32.17M 12.03B 2.57B | Net cash position 2023 | 41.54M 15.53B 3.32B | EV / Sales 2023 | -16,160,503 x |
| P/E ratio 2022 |
-123
x | P/E ratio 2023 |
-2.12
x | Employees | 3 |
| Yield 2022 |
17.9% | Yield 2023 |
-
| Free-Float | 63.62% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.28% | ||
| 1 week | +0.28% | ||
| Current month | -4.97% | ||
| 1 month | -4.97% | ||
| 3 months | -12.98% | ||
| 6 months | -18.62% | ||
| Current year | -10.22% |
1 week
351.00
355.30
1 month
330.00375.90
Current year
330.00465.60
1 year
330.00605.00
3 years
330.00885.80
5 years
121.30885.80
10 years
121.304 560.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ron Hadassi
CEO | Chief Executive Officer | 59 | 23/03/14 |
Riki Steiner
DFI | Director of Finance/CFO | 47 | - |
| Comptroller/Controller/Auditor | 51 | 31/12/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ron Hadassi
CEO | Chief Executive Officer | 59 | 23/03/14 |
Eliyahu Yoresh
BRD | Director/Board Member | 54 | 31/07/21 |
Yitshak Elias
BRD | Director/Board Member | 47 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 354 | +0.28% | 5 000 |
| 25/04/24 | 353 | 0.00% | 1,811 |
| 24/04/24 | 353 | -0.03% | 4,910 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 30, 2024 at 03:24 pm
More quotes
Elbit Imaging Ltd. engages, directly and through its investee companies, in the fields of commercial centers, hotels, medical industries and devices, and plots in India. The Company's segments include Commercial centers, Hotel, Medical Industries and devices, and Plots in India. Commercial centers segment include initiation, construction and sale of commercial centers and other mixed-use real property projects, principally in the retail sector. Hotel segment is engaged in the operation and management of hotels. Medical Industries and devices segment includes research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. Plots in India segment includes plots designated for sale, initially designated to residential projects.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.22% | 10M | |
| +39.94% | 28.07B | |
| -13.85% | 26.92B | |
| +22.78% | 26.28B | |
| +1.61% | 26.06B | |
| +49.67% | 22.69B | |
| +5.96% | 20.3B | |
| +3.66% | 19.59B | |
| +30.95% | 16.31B | |
| -10.00% | 15.21B |
- Stock Market
- Equities
- EMITF-M Stock
